Celex Oncology’s first attendance at Bio-Europe Spring 2025 follows their recent win at the 2024 EIT Health Catapult ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations.

A collaborative research team from The University of Hong Kong (HKU) and West China Hospital of Sichuan University has made a ...

Cancer metastasis, the spread of cancer to organs, is a major cause of cancer-related deaths. Once cancer spreads to multiple ...

Researchers at the Garvan Institute of Medical Research have uncovered how pancreatic cancer hijacks a crucial metabolism ...

The treatment* has the potential to control metastatic cancer and block the ... cell processes and tumour cell behaviour. This novel mechanism of action and new target is supported by robust ...

Circadian rhythms are endogenous time-keeping mechanisms that regulate physiological processes in response to external ...

The treatment* has the potential to control metastatic cancer and block the processes that lead to advanced metastatic disease, which is responsible for approximately 90% of all cancer deaths ...

Scientists at the Garvan Institute of Medical Research have found that pancreatic cancer uses a key metabolic switch to help ...